News

Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared to their White counterparts, data suggest.
The FDA issued another complete response letter for odronextamab for the treatment of relapsed/refractory follicular lymphoma.
Future prospective studies will be necessary to assess potential causation of sucralose in driving immunotherapy resistance as well as to determine how other demographic factors, including location ...
Resection beyond contrast-enhancing tumor margins is associated with superior outcomes in patients with primary glioblastoma, a study suggests.
The US Food and Drug Administration (FDA) has granted fast track designation to ateganosine (THIO, 6-thio-dG or 6-thio-2’-deoxyguanosine) for the treatment of non-small cell lung cancer (NSCLC).
More than 63 million Americans are caregivers for a family member with complex medical needs, according to a new report.
Designating GG1 on biopsy as noncancer without considering the prognostic values of adverse clinical features may lead to undertreatment and an increased risk of cancer-specific death in men with ...
The US Food and Drug Administration (FDA) has granted priority review to durvalumab for the treatment of patients with resectable, stage II-IVA gastric or gastroesophageal junction (GEJ) cancer.
The gender pay gap for US physicians hit 26% in 2024, which was an increase from the 23% pay gap observed in 2023, according to Doximity’s Physician Compensation Report 2025.
(HealthDay News) — Cannabis use disorder (CUD) is associated with an increased risk for oral cancer, according to a study published in Preventive Medicine Reports.
A person’s risk of developing lung cancer may increase with increasing consumption of ultra-processed foods, according to research published in Thorax. Researchers found that pa ...
During his first term, Trump signed the “Right to Try” law, which allows terminally ill patients to seek treatments that haven’t been fully approved by the FDA, the AP reported.